Citation | Manera, C; Malfitano, AM; Parkkari, T; Lucchesi, V; Carpi, S; Fogli, S; Bertini, S; Laezza, C; Ligresti, A; Saccomanni, G; Savinainen, JR; Ciaglia, E; Pisanti, S; Gazzerro, P; Di Marzo, V; Nieri, P; Macchia, M; Bifulco, M New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity. Eur J Med Chem97:10-8 (2015) [PubMed] Article |
---|
SMILES | CC1CCC(CC1)NC(=O)c1c(O)c2cccnc2n(CCCO)c1=O |(9.06,6.01,;7.99,5.4,;6.66,6.17,;5.33,5.4,;5.33,3.86,;6.66,3.09,;7.99,3.86,;3.99,3.08,;3.99,1.54,;5.06,.93,;2.66,.77,;1.33,1.54,;1.33,2.77,;,.77,;-1.33,1.54,;-2.68,.77,;-2.68,-.77,;-1.33,-1.54,;,-.77,;1.33,-1.54,;1.33,-3.08,;2.67,-3.85,;2.67,-5.39,;3.74,-6,;2.66,-.77,;3.73,-1.38,)| |